Sibopirdine

Sibopirdine
Clinical data
ATC code	none;
Legal status
Legal status	In general: unscheduled;
Pharmacokinetic data
Bioavailability	sus
Metabolism	sus
Excretion	sus
Identifiers
	IUPAC name 5,5-bis(4-pyridylmethyl)-5H-cyclopenta[2,1-b:3,4-b']dipyridine;
CAS Number	139781-09-2 ; anhydrous: 122955-18-4 ;
PubChem CID	9929210;
ChemSpider	169416 ;
UNII	RAG2185DR1; anhydrous: 7IKM67CSEQ ;
KEGG	D05833 ;
CompTox Dashboard (EPA)	DTXSID60930596 ;
Chemical and physical data
Formula	C23H18N4
Molar mass	350.425 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES c5cnccc5CC1(Cc3ccncc3)c2cccnc2-c4c1cccn4;
	InChI InChI=1S/C23H18N4/c1-3-19-21(26-9-1)22-20(4-2-10-27-22)23(19,15-17-5-11-24-12-6-17)16-18-7-13-25-14-8-18/h1-14H,15-16H2 ; Key:FJYRSJDIZKTXKB-UHFFFAOYSA-N ;
	(what is this?) (verify)

Sibopirdine, also known as EXP921, is a nootropic drug.^[1]

Synthesis

Patent:^[2]

4,5-Diazafluoren-9-one [50890-67-0] (1) is condensed with 4 molar equivalents of 4-picoline [108-89-4] (2) in the presence of 2 equivalents of acetic anhydride and acetic acid. The intermediate from this step may originally be a tertiary alcohol which then dehydrates under the reaction conditions to give [150896-71-2] (3). The olefin can then be reduced either by catalytic hydrogenation over 5% Pd/C or by sodium borohydride in alcohol to give [150896-72-3] (4). Alkylation with 4-picolyl chloride [10445-91-7] (5) in the presence of sodium hydroxide completed the synthesis of sibopirdine (6).

References

↑ Wong YN, Quon CY, Holm KA, Burcham DL, Frey NL, Huang SM, Lam GN (February 1996). "Pharmacokinetics and metabolism of EXP921, a novel cognitive enhancer, in rats". Drug Metabolism and Disposition. 24 (2): 172–9. doi:10.1016/S0090-9556(25)07294-0. PMID 8742228.
↑ James H. Jensen, Timothy D. Costello, Leon De Brabander, Jr., Matthew E. Voss, U.S. patent 5,272,269 (1993 to DuPont Merck Pharmaceutical Company).

This drug article relating to the nervous system is a stub. You can help Wikipedia by adding missing information.

[1] Wong YN, Quon CY, Holm KA, Burcham DL, Frey NL, Huang SM, Lam GN (February 1996). "Pharmacokinetics and metabolism of EXP921, a novel cognitive enhancer, in rats". Drug Metabolism and Disposition. 24 (2): 172–9. doi:10.1016/S0090-9556(25)07294-0. PMID 8742228.

[2] James H. Jensen, Timothy D. Costello, Leon De Brabander, Jr., Matthew E. Voss, U.S. patent 5,272,269 (1993 to DuPont Merck Pharmaceutical Company).

[1]

[2]

This page was redesigned at the edge.

Sibopirdine

Synthesis

See also

References